BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 5700611)

  • 1. [Comparative effectiveness of various correctors of the neurologic side effects of neruoleptic drugs].
    Magalif AIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1381-7. PubMed ID: 5700611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Psychopharmacologic study of 8909 RP (Neuleptil) by Wittenborn's Psychiatric Status Rating Scale].
    Beauseigneur-Nuyts T; Vallet R; Le Viet MQ
    Encephale; 1964; 53(3):405-14. PubMed ID: 4388707
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study of the activity of 2 neuroleptics].
    Blanc M; Borenstein P; Brion S; Buisson JF; Debray HR; Digo R; Flavigny H; Follin S; Minvielle J; Morel-Maroger A; Pichot P; Rainaut J; Sutter JM
    Encephale; 1970; 59(2):97-161. PubMed ID: 5458713
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of ethopropazine and trihexyphenidyl on several parameters of the neuroleptic syndrome].
    Elie R; Morin L; Tétreault L
    Encephale; 1972; 61(1):32-52. PubMed ID: 4403697
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indications for the use of neuleptil. Review of the literature and clinical contribution].
    Catalano A; Del Pistoia L; De Risio C; Ridolo P
    Riv Sper Freniatr Med Leg Alien Ment; 1967; 91():Suppl 5:1307+. PubMed ID: 4388059
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential study of 2 long-acting neuroleptics, fluphenazine enanthate and pipothiazine undecylenate.
    Gayral LF; Escande MM; Fournie HC; Huron RJ
    Therapie; 1973; 28(3):611-25. PubMed ID: 4771904
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
    Klett CJ; Caffey E
    Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
    [No Abstract]   [Full Text] [Related]  

  • 8. [Frenolon in psychiatry. A few thoughts on a new neuroleptic from the group of phenothiazines].
    Pagàn J
    Lyon Med; 1967 Jun; 217(26):951-4. PubMed ID: 5611642
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in clinical effects of three phenothiazines in "acute" schizophrenia.
    Dis Nerv Syst; 1967 Jun; 28(6):369-83. PubMed ID: 5342391
    [No Abstract]   [Full Text] [Related]  

  • 10. [Side effects of methylperone in long-term therapy up to 8 years].
    Kirkegaard G; Kirkegaard A
    Arzneimittelforschung; 1974 Aug; 24(8):1115-7. PubMed ID: 4213783
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the problem of the general and elective action of psycholeptics in the therapy of schizophrenia].
    Smulevich AB; Golovan' LI; Sokolova ED; Tsutsul'kovskaia MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):246-50. PubMed ID: 5655743
    [No Abstract]   [Full Text] [Related]  

  • 12. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O; Heller S
    Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experience with 19.552 R.P. in Nordic countries.
    Kristjansen P; Dencker SJ; Elley J; Hakola A; Heshe J; Malm U; Robak OH; Salvesen C; Vaksdal K
    Acta Psychiatr Scand Suppl; 1973; 246():42-7. PubMed ID: 4148911
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experimentation with a long-acting neuroleptic fluspirilene (R 6218)].
    Luyckx A
    Acta Psychiatr Belg; 1972 Nov; 72(6):748-55. PubMed ID: 4679557
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluspirilene and pipothiazine undecylenate, two long-acting injectable neuroleptics. A double-blind controlled trial in residual schizophrenia.
    Vereecken JL; Tanghe A
    Psychiatr Neurol Neurochir; 1972; 75(2):117-27. PubMed ID: 5030483
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative clinical-psychiatric experiences with thiaxanthene-derivatives with special consideration of flupenthixol].
    Poeldinger W
    Arzneimittelforschung; 1967 Sep; 17(9):1133-5. PubMed ID: 5632287
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of indication for use of antiparkinson medication. A follow-up study.
    Pecknold JC; Ananth JV; Ban TA; Lehmann HE
    Dis Nerv Syst; 1971 Aug; 32(8):538-41. PubMed ID: 5094160
    [No Abstract]   [Full Text] [Related]  

  • 18. [Initial results of clinical trial of a new long-acting neuroleptic agent: Fluspirelene].
    Ciccarelli G; Nosè F
    Minerva Med; 1971 Dec; 62(98):4922-7. PubMed ID: 5141918
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L
    Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluspirilene in the treatment of chronic schizophrenic outpatients.
    St-Laurent J; Carle R; Domingue D
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):599-608. PubMed ID: 4628682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.